1. Measles outbreaks continue unabated : CSAT-1
UPSC Syllabus : Economic growth, inflation
UPSC Syllabus : Indian Society
UPSC Syllabus : Indian polity
UPSC Syllabus : Role of media and social networking sites in internal security challenges
A typhoid vaccine (Typbar TCV) developed by the Hyderabadbased Bharat Biotech has shown 81.6% efficacy in preventing typhoid fever at 12 months in a phase3 clinical trial. The trial was carried out in Nepal in over 10,000 children who received the vaccine..
Copyright @ 2010 Classic IAS Academy All Rights Reserved (A Unit of Wezen Education Pvt. Ltd.)